11 – 15 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2018
-
Mark
Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis
(
- Contribution to journal › Article
- 2017
-
Mark
Endothelial dysfunction is associated with activation of the type I interferon system and platelets in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2016
-
Mark
Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.
(
- Contribution to journal › Article
- 2015
-
Mark
Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »